SCHEMBL6855748

SCHEMBL6855748

CCCCC(C)OC(=O)c1cc(C(=O)OC(C)CCCC)cc(S(=O)(=O)[O-])c1.CCCCC(C)OC(=O)c1cc(C(=O)OC(C)CCCC)cc(S(=O)(=O)[O-])c1.[Ba+2]

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 2/20 0.45
PRKCD Q05655 2/20 0.45
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.37
NR1I2 O75469 1/20 0.35
KMT2A Q03164 1/20 0.34
FAAH O00519 5/20 0.34
CA2 P00918 2/20 0.34
MMP9 P14780 1/20 0.34
MMP13 P45452 1/20 0.34
MAPT P10636 1/20 0.34
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
NAAA Q02083 1/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA14 Q9ULX7 1/20 0.33
MMP1 P03956 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6293031 0.97 PRKCA (0.45) PRKCAPRKCDALDH1A1TSHRNR1I2
SCHEMBL6850436 0.96 ALDH1A1 (0.46) PRKCAPRKCDALDH1A1TSHRNR1I2
SCHEMBL6856384 0.95 ALDH1A1 (0.48) PRKCAPRKCDALDH1A1NR1I2KMT2A
SCHEMBL6295996 0.93 ALDH1A1 (0.46) PRKCAPRKCDALDH1A1TSHRNR1I2
SCHEMBL6296114 0.92 ALDH1A1 (0.48) PRKCAPRKCDALDH1A1NR1I2KMT2A
SCHEMBL6856281 0.92 PRKCA (0.43) PRKCAPRKCDALDH1A1TSHRNR1I2
SCHEMBL6291923 0.89 PRKCA (0.43) PRKCAPRKCDALDH1A1TSHRNR1I2
SCHEMBL6855749 0.85 PRKCA (0.46) PRKCAPRKCDALDH1A1TSHRKMT2A
SCHEMBL6293032 0.85 PRKCA (0.46) PRKCAPRKCDALDH1A1TSHRKMT2A
SCHEMBL6854226 0.83 CA2 (0.37) PRKCAPRKCDTSHRKMT2ACA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6830859-B2 Electrostatic latent images; containing barium salt of sulfoisophthalic acid RICOH COMPANY, LTD. (JP) 2004-12-14 US disclosed
US-20030077534-A1 Charge control agent and toner using same RICOH COMPANY, LTD. (JP) 2003-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030077534-A1 Charge control agent and toner using same BET1, SMARCA5, SMARCA1 PRKCA 4466/4885PRKCD 4692/4885ALDH1A1 4656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.